Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial.
about
Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSERisk-adapted monitoring is not inferior to extensive on-site monitoring: Results of the ADAMON cluster-randomised study.The impact of medication nonadherence on the relationship between mortality risk and depression in heart failure.Acceptance of Antidepressant Treatment by Patients on Hemodialysis and Their Renal Providers.Symptom burden in heart failure: assessment, impact on outcomes, and management.Psychological Aspects of Heart Failure.Psychocardiology in the elderly.Symptom management challenges in heart failure: pharmacotherapy considerations.[Depression and heart failure - a twofold hazard? : Diagnosis, prognostic relevance and treatment of an underestimated comorbidity].Polygenic loading for major depression is associated with specific medical comorbidity.Comorbidity "depression" in heart failure - Potential target of patient education and self-managementPURLs: SSRIs for depression/heart failure patients? Not so fast.Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association.Collaborative Care and Related Interventions in Patients With Heart Disease: An Update and New Directions.Anxiety and self-care behaviour in patients with chronic systolic heart failure: A multivariate model.General practitioners' awareness of depressive symptomatology is not associated with quality of life in heart failure patients - cross-sectional results of the observational RECODE-HF Study.The effect of antidepressant medications in the management of heart failure on outcomes: mortality, cardiovascular function and depression - a systematic review.Heart-brain Interactions in Heart Failure
P2860
Q33610031-C7A4AF0F-DD31-4208-8D2D-9C9D7B681841Q38635306-A3F734F6-36A4-43C6-A7E2-7D8F300F6A01Q38654636-80C3ACDE-6D5A-48EB-9925-03E8B5EFD901Q38765349-31C72D65-3BDD-407D-9388-11035B31DFE7Q38945834-6A13B470-8C05-4E6A-955E-93E5B268A3E6Q38994782-AD740D36-EE9A-439E-96C8-02140F2AFAABQ39023153-BBEE5B39-3DF5-4D03-8FC8-2D347FD9945FQ39395575-31592909-8E64-424F-99A8-AB78944596C8Q40535889-0B0A761E-CBA6-4A9F-B1ED-9C438A6761B9Q42257142-BECD1D0E-D336-48A0-9A16-A6387A777B1FQ42321424-32EDD506-75F6-4136-A647-0EA18A07B8FAQ42741667-1FA28B5E-CE09-47CE-B9B0-35062E32D407Q47160609-C47FCC33-5538-44AD-AE55-CCD1B776525AQ47217070-B50C7E71-1060-41F1-87B2-99D6A2BD6787Q47587203-A87CFB32-2FDC-48FE-8781-430464213E6CQ47666177-2BBFB3B6-2882-45D2-A1D6-59A9C9583B51Q47683798-3D45380C-9D79-4AE1-B255-39E57AA2EE62Q47697279-ADD34D8B-85C0-4029-99A8-3023D9189EFBQ58804684-4A6DD56B-E9AE-471D-B655-55E0103EE3F8
P2860
Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Effect of Escitalopram on All- ...... -HF Randomized Clinical Trial.
@en
type
label
Effect of Escitalopram on All- ...... -HF Randomized Clinical Trial.
@en
prefLabel
Effect of Escitalopram on All- ...... -HF Randomized Clinical Trial.
@en
P2093
P50
P356
P1476
Effect of Escitalopram on All- ...... -HF Randomized Clinical Trial.
@en
P2093
Christiane E Angermann
Christiane Prettin
Frank Edelmann
Georg Ertl
Götz Gelbrich
Hermann Faller
Hilka Gunold
Ingrid Kindermann
Jürgen Deckert
MOOD-HF Study Investigators and Committee Members
P304
P356
10.1001/JAMA.2016.7635
P407
P577
2016-06-01T00:00:00Z